Levocabastine

Author:Prof. Dr. med. Peter Altmeyer

All authors of this article

Last updated on: 29.10.2020

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

H 1 antagonist for topical application.

IndicationThis section has been translated automatically.

Allergic rhinitis.

Limited indicationThis section has been translated automatically.

Second and third trimester pregnancy, renal insufficiency.

Dosage and method of useThis section has been translated automatically.

Nasal spray: 2-4 times/day 2 sprays in each nostril. Eye drops: 2-4 times/day 1 trp. in each eye.

Standard concentrationThis section has been translated automatically.

Nasal spray/eye drops: 0.05%.

Undesirable effectsThis section has been translated automatically.

Allergic reactions, headache, fatigue, dyspnoea, cough, nausea, potential carcinogen.

ContraindicationThis section has been translated automatically.

Hypersensitivity to the active substance, 1st trimester pregnancy.

PreparationsThis section has been translated automatically.

Livocab, Levophta

Authors

Last updated on: 29.10.2020

Author: Prof. Dr. med. Peter Altmeyer